4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Changes in Board, Management or Compensation, Reg. FD
Stockholders Approve Share Issuance at Heron Therapeutics Meeting
News
Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value
Material Contracts, News, Articles of Incorporation
Material Contracts
Announces Q2 2025 Financial Results and Highlights Commercial Progress, Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile
Shareholder votes
Q2
Q1
Q3
FY 2023
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration of Securities
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload